APRINOIA Therapeutics Statistics
Total Valuation
APRI has a market cap or net worth of $295.47 million. The enterprise value is $302.68 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
APRI has 26.86 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 26.86M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.35 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 33.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $126,847 |
| Profits Per Employee | -$301,944 |
| Employee Count | 72 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, APRI has paid $64,000 in taxes.
| Income Tax | 64,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APRI had revenue of $9.13 million and -$21.74 million in losses. Loss per share was -$0.81.
| Revenue | 9.13M |
| Gross Profit | 9.13M |
| Operating Income | -21.16M |
| Pretax Income | -21.68M |
| Net Income | -21.74M |
| EBITDA | -19.63M |
| EBIT | -20.18M |
| Loss Per Share | -$0.81 |
Full Income StatementBalance Sheet
The company has $8.39 million in cash and $15.60 million in debt, giving a net cash position of -$7.20 million or -$0.27 per share.
| Cash & Cash Equivalents | 8.39M |
| Total Debt | 15.60M |
| Net Cash | -7.20M |
| Net Cash Per Share | -$0.27 |
| Equity (Book Value) | -81.39M |
| Book Value Per Share | -3.03 |
| Working Capital | -20.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.88 million and capital expenditures -$1.26 million, giving a free cash flow of -$14.14 million.
| Operating Cash Flow | -12.88M |
| Capital Expenditures | -1.26M |
| Free Cash Flow | -14.14M |
| FCF Per Share | -$0.53 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -231.67% and -238.04%.
| Gross Margin | 100.00% |
| Operating Margin | -231.67% |
| Pretax Margin | -237.34% |
| Profit Margin | -238.04% |
| EBITDA Margin | -214.98% |
| EBIT Margin | -220.94% |
| FCF Margin | -154.81% |
